866-997-4948(US-Canada Toll Free)

United States Poliomyelitis Vaccine Market Report 2017

Published By :

QYResearch

Published Date : May 2017

Category :

Pharmaceutical

No. of Pages : 98 Pages

In this report, the United States Poliomyelitis Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Poliomyelitis Vaccine in these regions, from 2012 to 2022 (forecast).

United States Poliomyelitis Vaccine market competition by top manufacturers/players, with Poliomyelitis Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
GSK
Sanofi-Pasteur
Merck
Crucell
China National Biotech Group
Eli Lilly
...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Poliomyelitis Vaccine
Poliomyelitis Vaccine
Poliomyelitis Vaccine
Oral Poliomyelitis Vaccine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Poliomyelitis Vaccine for each application, including
VAPP
VDPV

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Poliomyelitis Vaccine Market Report 2017
1 Poliomyelitis Vaccine Overview
1.1 Product Overview and Scope of Poliomyelitis Vaccine
1.2 Classification of Poliomyelitis Vaccine by Product Category
1.2.1 United States Poliomyelitis Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Poliomyelitis Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Poliomyelitis Vaccine
1.2.4 Poliomyelitis Vaccine
1.2.5 Poliomyelitis Vaccine
1.2.6 Oral Poliomyelitis Vaccine
1.3 United States Poliomyelitis Vaccine Market by Application/End Users
1.3.1 United States Poliomyelitis Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 VAPP
1.3.3 VDPV
1.4 United States Poliomyelitis Vaccine Market by Region
1.4.1 United States Poliomyelitis Vaccine Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Poliomyelitis Vaccine Status and Prospect (2012-2022)
1.4.3 Southwest Poliomyelitis Vaccine Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Poliomyelitis Vaccine Status and Prospect (2012-2022)
1.4.5 New England Poliomyelitis Vaccine Status and Prospect (2012-2022)
1.4.6 The South Poliomyelitis Vaccine Status and Prospect (2012-2022)
1.4.7 The Midwest Poliomyelitis Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Poliomyelitis Vaccine (2012-2022)
1.5.1 United States Poliomyelitis Vaccine Sales and Growth Rate (2012-2022)
1.5.2 United States Poliomyelitis Vaccine Revenue and Growth Rate (2012-2022)

2 United States Poliomyelitis Vaccine Market Competition by Players/Suppliers
2.1 United States Poliomyelitis Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Poliomyelitis Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Poliomyelitis Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Poliomyelitis Vaccine Market Competitive Situation and Trends
2.4.1 United States Poliomyelitis Vaccine Market Concentration Rate
2.4.2 United States Poliomyelitis Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Poliomyelitis Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Poliomyelitis Vaccine Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Poliomyelitis Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Poliomyelitis Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Poliomyelitis Vaccine Price by Region (2012-2017)

4 United States Poliomyelitis Vaccine Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Poliomyelitis Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Poliomyelitis Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Poliomyelitis Vaccine Price by Type (2012-2017)
4.4 United States Poliomyelitis Vaccine Sales Growth Rate by Type (2012-2017)

5 United States Poliomyelitis Vaccine Sales (Volume) by Application (2012-2017)
5.1 United States Poliomyelitis Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Poliomyelitis Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Poliomyelitis Vaccine Players/Suppliers Profiles and Sales Data
6.1 GSK
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Poliomyelitis Vaccine Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GSK Poliomyelitis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Sanofi-Pasteur
6.2.2 Poliomyelitis Vaccine Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Merck
6.3.2 Poliomyelitis Vaccine Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Merck Poliomyelitis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Crucell
6.4.2 Poliomyelitis Vaccine Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Crucell Poliomyelitis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 China National Biotech Group
6.5.2 Poliomyelitis Vaccine Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 China National Biotech Group Poliomyelitis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Eli Lilly
6.6.2 Poliomyelitis Vaccine Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Eli Lilly Poliomyelitis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
...

7 Poliomyelitis Vaccine Manufacturing Cost Analysis
7.1 Poliomyelitis Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Poliomyelitis Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Poliomyelitis Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Poliomyelitis Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Poliomyelitis Vaccine Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Poliomyelitis Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Poliomyelitis Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Poliomyelitis Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Poliomyelitis Vaccine Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Poliomyelitis Vaccine
Figure United States Poliomyelitis Vaccine Market Size (Kg) by Type (2012-2022)
Figure United States Poliomyelitis Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Poliomyelitis Vaccine Product Picture
Figure Poliomyelitis Vaccine Product Picture
Figure Poliomyelitis Vaccine Product Picture
Figure Oral Poliomyelitis Vaccine Product Picture
Figure United States Poliomyelitis Vaccine Market Size (Kg) by Application (2012-2022)
Figure United States Sales Market Share of Poliomyelitis Vaccine by Application in 2016
Figure VAPP Examples
Figure VDPV Examples
Figure United States Poliomyelitis Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Poliomyelitis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Poliomyelitis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Poliomyelitis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Poliomyelitis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Poliomyelitis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Poliomyelitis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Poliomyelitis Vaccine Sales (Kg) and Growth Rate (2012-2022)
Figure United States Poliomyelitis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Poliomyelitis Vaccine Market Major Players Product Sales Volume (Kg) (2012-2017)
Table United States Poliomyelitis Vaccine Sales (Kg) of Key Players/Suppliers (2012-2017)
Table United States Poliomyelitis Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Poliomyelitis Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Poliomyelitis Vaccine Sales Share by Players/Suppliers
Figure United States Poliomyelitis Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Poliomyelitis Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Poliomyelitis Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Poliomyelitis Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Poliomyelitis Vaccine Revenue Share by Players/Suppliers
Table United States Market Poliomyelitis Vaccine Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Poliomyelitis Vaccine Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Poliomyelitis Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Poliomyelitis Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Poliomyelitis Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Poliomyelitis Vaccine Product Category
Table United States Poliomyelitis Vaccine Sales (Kg) by Region (2012-2017)
Table United States Poliomyelitis Vaccine Sales Share by Region (2012-2017)
Figure United States Poliomyelitis Vaccine Sales Share by Region (2012-2017)
Figure United States Poliomyelitis Vaccine Sales Market Share by Region in 2016
Table United States Poliomyelitis Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Poliomyelitis Vaccine Revenue Share by Region (2012-2017)
Figure United States Poliomyelitis Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Poliomyelitis Vaccine Revenue Market Share by Region in 2016
Table United States Poliomyelitis Vaccine Price (USD/Kg) by Region (2012-2017)
Table United States Poliomyelitis Vaccine Sales (Kg) by Type (2012-2017)
Table United States Poliomyelitis Vaccine Sales Share by Type (2012-2017)
Figure United States Poliomyelitis Vaccine Sales Share by Type (2012-2017)
Figure United States Poliomyelitis Vaccine Sales Market Share by Type in 2016
Table United States Poliomyelitis Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Poliomyelitis Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Poliomyelitis Vaccine by Type (2012-2017)
Figure Revenue Market Share of Poliomyelitis Vaccine by Type in 2016
Table United States Poliomyelitis Vaccine Price (USD/Kg) by Types (2012-2017)
Figure United States Poliomyelitis Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Poliomyelitis Vaccine Sales (Kg) by Application (2012-2017)
Table United States Poliomyelitis Vaccine Sales Market Share by Application (2012-2017)
Figure United States Poliomyelitis Vaccine Sales Market Share by Application (2012-2017)
Figure United States Poliomyelitis Vaccine Sales Market Share by Application in 2016
Table United States Poliomyelitis Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Poliomyelitis Vaccine Sales Growth Rate by Application (2012-2017)
Table GSK Basic Information List
Table GSK Poliomyelitis Vaccine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GSK Poliomyelitis Vaccine Sales Growth Rate (2012-2017)
Figure GSK Poliomyelitis Vaccine Sales Market Share in United States (2012-2017)
Figure GSK Poliomyelitis Vaccine Revenue Market Share in United States (2012-2017)
Table Sanofi-Pasteur Basic Information List
Table Sanofi-Pasteur Poliomyelitis Vaccine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi-Pasteur Poliomyelitis Vaccine Sales Growth Rate (2012-2017)
Figure Sanofi-Pasteur Poliomyelitis Vaccine Sales Market Share in United States (2012-2017)
Figure Sanofi-Pasteur Poliomyelitis Vaccine Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Poliomyelitis Vaccine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Merck Poliomyelitis Vaccine Sales Growth Rate (2012-2017)
Figure Merck Poliomyelitis Vaccine Sales Market Share in United States (2012-2017)
Figure Merck Poliomyelitis Vaccine Revenue Market Share in United States (2012-2017)
Table Crucell Basic Information List
Table Crucell Poliomyelitis Vaccine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Crucell Poliomyelitis Vaccine Sales Growth Rate (2012-2017)
Figure Crucell Poliomyelitis Vaccine Sales Market Share in United States (2012-2017)
Figure Crucell Poliomyelitis Vaccine Revenue Market Share in United States (2012-2017)
Table China National Biotech Group Basic Information List
Table China National Biotech Group Poliomyelitis Vaccine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure China National Biotech Group Poliomyelitis Vaccine Sales Growth Rate (2012-2017)
Figure China National Biotech Group Poliomyelitis Vaccine Sales Market Share in United States (2012-2017)
Figure China National Biotech Group Poliomyelitis Vaccine Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Poliomyelitis Vaccine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly Poliomyelitis Vaccine Sales Growth Rate (2012-2017)
Figure Eli Lilly Poliomyelitis Vaccine Sales Market Share in United States (2012-2017)
Figure Eli Lilly Poliomyelitis Vaccine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Poliomyelitis Vaccine
Figure Manufacturing Process Analysis of Poliomyelitis Vaccine
Figure Poliomyelitis Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Poliomyelitis Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Poliomyelitis Vaccine
Table Distributors/Traders List
Figure United States Poliomyelitis Vaccine Sales Volume (Kg) and Growth Rate Forecast (2017-2022)
Figure United States Poliomyelitis Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Poliomyelitis Vaccine Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Poliomyelitis Vaccine Sales Volume (Kg) Forecast by Type (2017-2022)
Figure United States Poliomyelitis Vaccine Sales Volume (Kg) Forecast by Type (2017-2022)
Figure United States Poliomyelitis Vaccine Sales Volume (Kg) Forecast by Type in 2022
Table United States Poliomyelitis Vaccine Sales Volume (Kg) Forecast by Application (2017-2022)
Figure United States Poliomyelitis Vaccine Sales Volume (Kg) Forecast by Application (2017-2022)
Figure United States Poliomyelitis Vaccine Sales Volume (Kg) Forecast by Application in 2022
Table United States Poliomyelitis Vaccine Sales Volume (Kg) Forecast by Region (2017-2022)
Table United States Poliomyelitis Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Poliomyelitis Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Poliomyelitis Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *